Garate-Soraluze E, Serrano-Mendioroz I, Fernandez-Rubio L, de Andrea C, Barrio-Alonso C, Herrero C
J Immunother Cancer. 2025; 13(2).
PMID: 39933836
PMC: 11815443.
DOI: 10.1136/jitc-2024-009852.
Chen C, Yang S, Chang P, Chen S, Nieh S, Huang W
Cells. 2024; 13(16.
PMID: 39195225
PMC: 11352219.
DOI: 10.3390/cells13161334.
Xu Q, La T, Ye K, Wang L, Wang S, Hu Y
Clin Transl Med. 2024; 14(6):e1734.
PMID: 38888967
PMC: 11185127.
DOI: 10.1002/ctm2.1734.
Qin S, Li C, Li R, Hu S, Li G, Sun M
Hua Xi Kou Qiang Yi Xue Za Zhi. 2024; 40(3):335-340.
PMID: 38597016
PMC: 9207803.
DOI: 10.7518/hxkq.2022.03.014.
Rahman M, Nguyen T, Lee G, Kim B, Park M, Lee C
Int J Mol Sci. 2024; 25(3).
PMID: 38338768
PMC: 10855792.
DOI: 10.3390/ijms25031489.
The Role of the Tumor Microenvironment in Triple-Positive Breast Cancer Progression and Therapeutic Resistance.
Pu Q, Gao H
Cancers (Basel). 2023; 15(22).
PMID: 38001753
PMC: 10670777.
DOI: 10.3390/cancers15225493.
Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota.
Li J, Ji Y, Chen N, Dai L, Deng H
Cell Biosci. 2023; 13(1):194.
PMID: 37875976
PMC: 10594787.
DOI: 10.1186/s13578-023-01139-8.
A new approach to overcoming resistance to immunotherapy: nanotechnology.
Shao J, Jin Y, Jin C
Front Oncol. 2023; 13:1210245.
PMID: 37637050
PMC: 10457008.
DOI: 10.3389/fonc.2023.1210245.
Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression.
Maharati A, Moghbeli M
J Transl Med. 2023; 21(1):556.
PMID: 37596669
PMC: 10439650.
DOI: 10.1186/s12967-023-04434-7.
Endothelial cell‑derived connective tissue growth factor stimulates fibroblast differentiation into myofibroblasts through integrin αVβ3.
Lee S
Exp Ther Med. 2022; 25(1):30.
PMID: 36561611
PMC: 9748665.
DOI: 10.3892/etm.2022.11730.
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer.
Monteran L, Ershaid N, Doron H, Zait Y, Scharff Y, Ben-Yosef S
Nat Commun. 2022; 13(1):5797.
PMID: 36184683
PMC: 9527249.
DOI: 10.1038/s41467-022-33598-x.
Cancer Resistance to Immunotherapy: Molecular Mechanisms and Tackling Strategies.
Vu S, Vetrivel P, Kim J, Lee M
Int J Mol Sci. 2022; 23(18).
PMID: 36142818
PMC: 9513751.
DOI: 10.3390/ijms231810906.
Study of the colonic epithelial-mesenchymal dialogue through establishment of two activated or not mesenchymal cell lines: Activated and resting ones differentially modulate colonocytes in co-culture.
Plaisancie P, Buisson C, Fouche E, Martin P, Noirot C, Maslo C
PLoS One. 2022; 17(8):e0273858.
PMID: 36040985
PMC: 9426876.
DOI: 10.1371/journal.pone.0273858.
Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer.
Zou Q, Lei X, Xu A, Li Z, He Q, Huang X
Front Immunol. 2022; 13:724139.
PMID: 35935996
PMC: 9353076.
DOI: 10.3389/fimmu.2022.724139.
The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches.
Zafari N, Khosravi F, Rezaee Z, Esfandyari S, Bahiraei M, Bahramy A
J Clin Lab Anal. 2022; 36(8):e24585.
PMID: 35808903
PMC: 9396196.
DOI: 10.1002/jcla.24585.
Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets.
Menezes S, Okail M, Jalil S, Kocher H, Cameron A
J Pathol. 2022; 257(4):526-544.
PMID: 35533046
PMC: 9327514.
DOI: 10.1002/path.5926.
Metabolic Regulation of Fibroblast Activation and Proliferation during Organ Fibrosis.
Wang S, Liang Y, Dai C
Kidney Dis (Basel). 2022; 8(2):115-125.
PMID: 35527985
PMC: 9021660.
DOI: 10.1159/000522417.
The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression.
Pernot S, Evrard S, Khatib A
Front Immunol. 2022; 13:850856.
PMID: 35493456
PMC: 9043524.
DOI: 10.3389/fimmu.2022.850856.
Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity.
Peng S, Li Y, Huang M, Tang G, Xie Y, Chen D
Int J Biol Sci. 2022; 18(5):1912-1932.
PMID: 35342344
PMC: 8935219.
DOI: 10.7150/ijbs.68484.
LncRNA: A Potential Target for Host-Directed Therapy of Infection.
Wang Y, Xu H, Chen N, Yang J, Zhou H
Pharmaceutics. 2022; 14(3).
PMID: 35335994
PMC: 8954347.
DOI: 10.3390/pharmaceutics14030621.